OT Staff Reports

Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD. 

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

Short drive times, access to transportation play role in maintaining eye health appointments

Here's how hospital stays can affect vision

JAMA Ophthalmology investigates the accuracy claims of this convenient modality 

Ophthalmology Times’ Editorial Advisory Board members share their thoughts on what to watch in year ahead